ESTROGEN RECEPTOR-COREGULATOR FUNCTIONAL INTERACTIONS
ESTROGEN RECEPTOR-COREGULATOR FUNCTIONAL INTERACTIONS
批准号:
9039033
负责人:
CAROLYN Louise SMITH
金额:
$37.64万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-09-22 至 2019-04-30
关键词:
3-Dimensional4-Hydroxy-TamoxifenAddressAgonistBindingBiologicalBoxingBreast Epithelial CellsC-terminalComplexDeacetylaseDevelopmentDiseaseEpigenetic ProcessEstradiolEstrogen Receptor alphaEstrogen ReceptorsEstrogensEvaluationGPS2 geneGene ExpressionGene Expression RegulationGene TargetingGenesGoalsHDAC3 geneHealthHistonesHomeostasisHumanInositolLigand BindingLigandsMammary glandMediatingModelingModificationMutateNatureOsteoporosisPathologic ProcessesPathologyPathway interactionsPhysiologicalPolyphosphatesProteinsRecruitment ActivityRegulationReproductionResearchRoleSMRT proteinSelective Estrogen Receptor ModulatorsSignal PathwaySignal TransductionSteroidsSurfaceTestingTherapeuticTissuesWorkbasehistone demethylasehistone methylationin vivoinsightmalignant breast neoplasmmammary gland developmentmouse modelnovelnovel strategiespreventreceptorresearch studyresponsethree-dimensional modelingtranscription factortranscriptomicstumorigenesis
中文摘要
描述(申请人提供):经典的雌激素受体,ERα,是一种受配体调节的转录因子,对正常发育、体内平衡和生殖至关重要,因此,了解该受体活性的正常和药物调节对人类健康具有重要意义。众所周知,ERα调节基因表达的能力依赖于配体结合的受体招募到其靶基因的转录辅助调节因子。维甲酸和甲状腺激素受体沉默调节剂最初被认为是选择性雌激素受体调节剂4-羟基三苯氧胺(4HT)与ERα结合的辅阻遏物,但它能刺激雌激素(E_2)结合的ERα的活性,从而使SMRT成为ERα的双重辅活制子/辅抑制子。最近的工作表明,SMRT与ERα相互作用的性质取决于受体是与激动剂还是拮抗剂结合。此外,除了被广泛描述的组蛋白脱乙酰基酶3(HDAC3)被SMRT激活外,这个辅助调节因子还可以与促进ERα转录活性的组蛋白去甲基酶结合。这项拟议工作的总体目标是确定两种具有激活和抑制活性的SMRT相互作用蛋白调控ERα依赖的基因表达的能力。计划中的实验将使用最先进的生物学、循环和转录分析来测试SMRT-ERα相互作用性质的差异是否有助于这些不同的复合体以配体和基因依赖的方式结合和/或调节ERα的能力,以及抑制复合体的组成或活性是否可以由细胞途径调节。利用维持类固醇反应的新型乳腺上皮细胞三维培养和能够在体内精确评估SMRT的HDAC3激活活性的小鼠模型,SMRT调节ERα转录活性和乳腺发育的能力将决定SMRT在生理环境中调节ERα对激动剂和拮抗剂的反应的生物学重要性。总之,这些计划中的研究将评估这样的假设,即SMRT招募到ERα靶基因的蛋白质的差异是这种辅助调节因子对ERα依赖的基因表达影响的关键决定因素。在这样做的过程中,拟议的工作将为独立于HDAC3的SMRT的作用机制以及SMRT在雌激素依赖疾病(如乳腺癌)中对ERα调控的贡献提供关键的见解。
英文摘要
DESCRIPTION (provided by applicant): The classical estrogen receptor, ERα, is a ligand-regulated transcription factor important for normal development, homeostasis and reproduction, and consequently, understanding normal and pharmacological regulation of this receptor's activity is of major significance to human health. It is well accepted that the ability of ERα to regulate gene expression is dependent upon the transcriptional coregulators that ligand-bound receptors recruit to their target genes. The silencing mediator of retinoic acid and thyroid hormone receptors (SMRT) coregulator was initially characterized as a corepressor for ERα bound to the selective estrogen receptor modulator (SERM), 4-hydroxytamoxifen (4HT), however, it can stimulate the activity of ERα bound to estradiol (E2) and this established SMRT as a dual coactivator/corepressor for ERα. Recent work demonstrates that the nature of SMRT interactions with ERα depend upon whether the receptor is bound to agonist or antagonist. Moreover, in addition to the well described activation of histone deacetylase 3 (HDAC3) by SMRT, this coregulator can also bind to a histone demethylase that promotes the transcriptional activity of ERα. The overall goal of the proposed work is to define the ability of two SMRT interacting proteins, with activating and repressive activities, respectively, to regulate ERα-dependent gene expression. The planned experiments will use state-of-the-art biological, cistromic and transcriptomic analysis to test whether differences in the nature of SMRT-ERα interactions contributes to the ability of these distinct complexes to bind and/or regulate ERα in a ligand- and gene-dependent manner, and whether the composition or activity of the repressive complexes can be regulated by cellular pathways. Using novel 3-dimensional culture of mammary epithelial cells that maintain steroid responsiveness and mouse models that enable the precise evaluation of the HDAC3 activation activity of SMRT in vivo, the ability of SMRT to regulate ERα transcriptional activity as well as mammary gland development will define the biological importance of SMRT for regulation of ERα responses to both agonists and antagonists in a physiological setting. Together, these planned studies will evaluate the hypothesis that differences in the proteins that SMRT recruits to ERα target genes are critical determinants of the effect of this coregulator on ERα-dependent gene expression. In so doing, the proposed work will provide critical insight into mechanisms of action of SMRT independent of HDAC3, and the contribution of SMRT to ERα regulation in estrogen-dependent disease such as breast cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Clinical Translational Research Certificate of Added Qualification Program
-
批准号:10192765
-
项目类别:
-
资助金额:$43.89万
-
财政年份:2020
-
负责人:CAROLYN Louise SMITH
-
依托单位:
The Clinical Translational Research Certificate of Added Qualification Program
-
批准号:10654873
-
项目类别:
-
资助金额:$42.44万
-
财政年份:2020
-
负责人:CAROLYN Louise SMITH
-
依托单位:
The Clinical Translational Research Certificate of Added Qualification Program
-
批准号:10440362
-
项目类别:
-
资助金额:$46.83万
-
财政年份:2020
-
负责人:CAROLYN Louise SMITH
-
依托单位:
Antiestrogen Regulation of Bladder Cancer
-
批准号:7622145
-
项目类别:
-
资助金额:$7.68万
-
财政年份:2008
-
负责人:CAROLYN Louise SMITH
-
依托单位:
Antiestrogen Regulation of Bladder Cancer
-
批准号:7471237
-
项目类别:
-
资助金额:$7.68万
-
财政年份:2008
-
负责人:CAROLYN Louise SMITH
-
依托单位:
Negative Regulation of Estrogen Receptors
-
批准号:7169625
-
项目类别:
-
资助金额:$24.26万
-
财政年份:2004
-
负责人:CAROLYN Louise SMITH
-
依托单位:
Negative Regulation of Estrogen Receptors
-
批准号:6724340
-
项目类别:
-
资助金额:$25.59万
-
财政年份:2004
-
负责人:CAROLYN Louise SMITH
-
依托单位:
Negative Regulation of Estrogen Receptors
-
批准号:6839504
-
项目类别:
-
资助金额:$25.59万
-
财政年份:2004
-
负责人:CAROLYN Louise SMITH
-
依托单位:
Negative Regulation of Estrogen Receptors
-
批准号:7009646
-
项目类别:
-
资助金额:$24.98万
-
财政年份:2004
-
负责人:CAROLYN Louise SMITH
-
依托单位:
CORE--CELL CULTURE
-
批准号:6594228
-
项目类别:
-
资助金额:$17.42万
-
财政年份:2002
-
负责人:CAROLYN Louise SMITH
-
依托单位:
CORE--CELL CULTURE
-
批准号:6440498
-
项目类别:
-
资助金额:$17.42万
-
财政年份:2001
-
负责人:CAROLYN Louise SMITH
-
依托单位:
CORE--CELL CULTURE
-
批准号:6564633
-
项目类别:
-
资助金额:$17.42万
-
财政年份:2001
-
负责人:CAROLYN Louise SMITH
-
依托单位:
CORE--CELL CULTURE
-
批准号:6324687
-
项目类别:
-
资助金额:$6.8万
-
财政年份:2000
-
负责人:CAROLYN Louise SMITH
-
依托单位:
CORE--CELL CULTURE
-
批准号:6108244
-
项目类别:
-
资助金额:$6.8万
-
财政年份:1999
-
负责人:CAROLYN Louise SMITH
-
依托单位:
CORE--CELL CULTURE
-
批准号:6271972
-
项目类别:
-
资助金额:$6.6万
-
财政年份:1998
-
负责人:CAROLYN Louise SMITH
-
依托单位:
Estrogen Receptor-Coregulator Functional Interactions
-
批准号:6606216
-
项目类别:
-
资助金额:$23.33万
-
财政年份:1997
-
负责人:CAROLYN Louise SMITH
-
依托单位:
Estrogen Receptor-Coregulator Functional Interactions
-
批准号:7843450
-
项目类别:
-
资助金额:$30.39万
-
财政年份:1997
-
负责人:CAROLYN Louise SMITH
-
依托单位:
Estrogen Receptor-Coregulator Functional Interactions
-
批准号:6780440
-
项目类别:
-
资助金额:$23.33万
-
财政年份:1997
-
负责人:CAROLYN Louise SMITH
-
依托单位:
Estrogen Receptor-Coregulator Functional Interactions
-
批准号:6919882
-
项目类别:
-
资助金额:$23.33万
-
财政年份:1997
-
负责人:CAROLYN Louise SMITH
-
依托单位:
ESTROGEN RECEPTOR-COREGULATOR FUNCTIONAL INTERACTIONS
-
批准号:9262908
-
项目类别:
-
资助金额:$37.64万
-
财政年份:1997
-
负责人:CAROLYN Louise SMITH
-
依托单位:
海外基金